Lifecore Biomedical, Inc. (LFCR): שולי רווח תפעולי

לוגו של חברה ציבורית Lifecore Biomedical (LFCR)

Lifecore Biomedical (LFCR) ensures supply chain stability through its network of biopharmaceutical production laboratories. The company generates revenue from the contract manufacturing of sterile injectables and hyaluronic acid for global biotech behemoths. Changes in operating margin demonstrate the actual quality of management, while 0.00 reflects the latest level of this metric. Business profitability relies on long-term orders and strict compliance with FDA standards.

Lifecore (LFCR): רווחיות מכירות תפעולית מ-28.04.2023 עד 19.11.2026

פילוחי מדדים ואנליטיקה של חברת Lifecore Biomedical (LFCR)

- מחיר מניה וקונצנזוס הערכת שווי:
הערכת שווי פונדמנטלית של החברה:Lifecore Biomedical, Inc., LFCR
מוצרים מוגמרים של Lifecore

Searching for fundamentally resilient assets requires analyzing a business's ability to generate cash flow. This metric measures the share of operating profit in revenue, excluding the impact of taxes and debt load. For Lifecore Biomedical (LFCR), this reflects the efficiency of executing current CDMO orders during the post-audit recovery period. The stability of the operating margin confirms a pivot away from expansion in favor of organic growth. The operating margin trend allows for a real-time assessment of the company's actual operational efficiency.